Cargando…
Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
DDX3 is an RNA helicase with oncogenic properties. The small molecule inhibitor RK-33 is designed to fit into the ATP binding cleft of DDX3 and hereby block its activity. RK-33 has shown potent activity in preclinical cancer models. However, the mechanism behind the antineoplastic activity of RK-33...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050443/ https://www.ncbi.nlm.nih.gov/pubmed/29684792 http://dx.doi.org/10.1016/j.tranon.2018.04.001 |
_version_ | 1783340337032331264 |
---|---|
author | Heerma van Voss, Marise R. Kammers, Kai Vesuna, Farhad Brilliant, Justin Bergman, Yehudit Tantravedi, Saritha Wu, Xinyan Cole, Robert N. Holland, Andrew van Diest, Paul J. Raman, Venu |
author_facet | Heerma van Voss, Marise R. Kammers, Kai Vesuna, Farhad Brilliant, Justin Bergman, Yehudit Tantravedi, Saritha Wu, Xinyan Cole, Robert N. Holland, Andrew van Diest, Paul J. Raman, Venu |
author_sort | Heerma van Voss, Marise R. |
collection | PubMed |
description | DDX3 is an RNA helicase with oncogenic properties. The small molecule inhibitor RK-33 is designed to fit into the ATP binding cleft of DDX3 and hereby block its activity. RK-33 has shown potent activity in preclinical cancer models. However, the mechanism behind the antineoplastic activity of RK-33 remains largely unknown. In this study we used a dual phosphoproteomic and single cell tracking approach to evaluate the effect of RK-33 on cancer cells. MDA-MB-435 cells were treated for 24 hours with RK-33 or vehicle control. Changes in phosphopeptide abundance were analyzed with quantitative mass spectrometry using isobaric mass tags (Tandem Mass Tags). At the proteome level we mainly observed changes in mitochondrial translation, cell division pathways and proteins related to cell cycle progression. Analysis of the phosphoproteome indicated decreased CDK1 activity after RK-33 treatment. To further evaluate the effect of DDX3 inhibition on cell cycle progression over time, we performed timelapse microscopy of Fluorescent Ubiquitin Cell Cycle Indicators labeled cells after RK-33 or siDDX3 exposure. Single cell tracking indicated that DDX3 inhibition resulted in a global delay in cell cycle progression in interphase and mitosis. In addition, we observed an increase in endoreduplication. Overall, we conclude that DDX3 inhibition affects cells in all phases and causes a global cell cycle progression delay. |
format | Online Article Text |
id | pubmed-6050443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60504432018-07-19 Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach Heerma van Voss, Marise R. Kammers, Kai Vesuna, Farhad Brilliant, Justin Bergman, Yehudit Tantravedi, Saritha Wu, Xinyan Cole, Robert N. Holland, Andrew van Diest, Paul J. Raman, Venu Transl Oncol Original article DDX3 is an RNA helicase with oncogenic properties. The small molecule inhibitor RK-33 is designed to fit into the ATP binding cleft of DDX3 and hereby block its activity. RK-33 has shown potent activity in preclinical cancer models. However, the mechanism behind the antineoplastic activity of RK-33 remains largely unknown. In this study we used a dual phosphoproteomic and single cell tracking approach to evaluate the effect of RK-33 on cancer cells. MDA-MB-435 cells were treated for 24 hours with RK-33 or vehicle control. Changes in phosphopeptide abundance were analyzed with quantitative mass spectrometry using isobaric mass tags (Tandem Mass Tags). At the proteome level we mainly observed changes in mitochondrial translation, cell division pathways and proteins related to cell cycle progression. Analysis of the phosphoproteome indicated decreased CDK1 activity after RK-33 treatment. To further evaluate the effect of DDX3 inhibition on cell cycle progression over time, we performed timelapse microscopy of Fluorescent Ubiquitin Cell Cycle Indicators labeled cells after RK-33 or siDDX3 exposure. Single cell tracking indicated that DDX3 inhibition resulted in a global delay in cell cycle progression in interphase and mitosis. In addition, we observed an increase in endoreduplication. Overall, we conclude that DDX3 inhibition affects cells in all phases and causes a global cell cycle progression delay. Neoplasia Press 2018-04-24 /pmc/articles/PMC6050443/ /pubmed/29684792 http://dx.doi.org/10.1016/j.tranon.2018.04.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original article Heerma van Voss, Marise R. Kammers, Kai Vesuna, Farhad Brilliant, Justin Bergman, Yehudit Tantravedi, Saritha Wu, Xinyan Cole, Robert N. Holland, Andrew van Diest, Paul J. Raman, Venu Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title | Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title_full | Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title_fullStr | Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title_full_unstemmed | Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title_short | Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach |
title_sort | global effects of ddx3 inhibition on cell cycle regulation identified by a combined phosphoproteomics and single cell tracking approach |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050443/ https://www.ncbi.nlm.nih.gov/pubmed/29684792 http://dx.doi.org/10.1016/j.tranon.2018.04.001 |
work_keys_str_mv | AT heermavanvossmariser globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT kammerskai globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT vesunafarhad globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT brilliantjustin globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT bergmanyehudit globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT tantravedisaritha globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT wuxinyan globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT colerobertn globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT hollandandrew globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT vandiestpaulj globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach AT ramanvenu globaleffectsofddx3inhibitiononcellcycleregulationidentifiedbyacombinedphosphoproteomicsandsinglecelltrackingapproach |